Cochrane · systematic review · CD008276

Pharmacotherapy for hypertension in adults aged 18 to 59 years

Musini, VM, Gueyffier, F, Puil, L, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library

HypertensionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 42.9%Low 4 · 57.1%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Antihypertensive drug therapy compared to control for hypertension in adults aged 18 to 59 years

Population: adults aged 18‐59 years with primary hypertension (mild to moderate systolic or diastolic hypertension)
7 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality
Antihypertensive drug therapy vs control
RR 0.94 [0.77, 1.13]5 studies · 16776 participantsLow
Total cardiovascular mortality + morbidity
Antihypertensive drug therapy vs control
RR 0.78 [0.67, 0.91]6 studies · 17278 participantsLow
Cerebrovascular mortality + morbidity
Antihypertensive drug therapy vs control
RR 0.46 [0.34, 0.64]6 studies · 17278 participantsLow
Coronary heart disease mortality + morbidity
Antihypertensive drug therapy vs control
RR 0.99 [0.82, 1.19]4 studies · 16241 participantsLow
Withdrawal due to adverse events
Antihypertensive drug therapy vs control
RR 4.82 [1.67, 13.92]3 studies · 1223 participantsVery low
Decrease in SBP5 at end of 1 year
Antihypertensive drug therapy vs control
no estimate extracted3 studies · 14845 participantsVery low
Decrease in DBP6 at end of 1 year
Antihypertensive drug therapy vs control
no estimate extracted4 studies · 15857 participantsVery low